The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Valtrex 500mg Film-coated tablets

GlaxoSmithKline (Ireland) LimitedPA1077/082/002

Main Information

Trade NameValtrex 500mg Film-coated tablets
Active SubstancesValaciclovir
Dosage FormFilm-coated tablet
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/082/002

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB11 valaciclovir


License statusAuthorised
Licence Issued20/12/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back